Clinical Trials List
2014-01-01 - 2016-12-31
Phase III
Terminated8
-
Trial Applicant
TSH BIOPHARM CORPORATION LTD.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Kang-Ling Wang Division of Cardiovascular Diseases
- 林幸榮 Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- Tse-Min Lu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Yu-Cheng Hsieh Division of Cardiovascular Diseases
- JIN–LONG HUANG Division of Cardiovascular Diseases
- WEI-WEN LIN Division of Cardiovascular Diseases
- 何鴻鋆 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 朱志生 Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
- 鄭凱鴻 Division of Cardiovascular Diseases
- 溫文才 Division of Cardiovascular Diseases
- Tsung-Hsien Lin Division of Cardiovascular Diseases
- 顏學偉 Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- Cheng-An Chiu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 方修御 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
143 participants
-
Global
0 participants
